AstraZeneca eyes US expansion despite Trump tariff threat

LONDON: British pharmaceutical giant AstraZeneca has doubled down on plans to grow its US business as it braces for the country’s potential tariffs on the pharmaceutical industry, PA Media/dpa reported. The drug maker said on Tuesday it is “firmly …

AstraZeneca moves some production to US amid tariff threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector. Other pharmaceutical companies have also …

AstraZeneca reports strong first quarter

The FTSE 100 drugmaker said product sales rose 9% to $12.88bn, while reported earnings per share climbed 34% to $1.89 and core EPS increased 21% to $2.49. Core operating profit grew 12%, and the company maintained its full-year guidance for high single- …

AstraZeneca says potential US tariffs manageable, faces another China fine

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, asserting it would maintain its 2025 forecasts if the levies end up being in line with other sectors. The tariffs and their …

British drugs giant AstraZeneca doubles down on US manufacturing amid tariff threat

Drugmaker boosts investment in US where it makes 40% of sales Revenues rise 10% in the first quarter but shares fall amid tariff concerns   By MIKE SHEEN Updated: 07:03 EDT, 29 April 2025 AstraZeneca is bolstering its US manufacturing presence as President …

FTSE 100 Live 29 April: BP and AstraZeneca dent index, AB Foods slumps on sugar loss

Ladbrokes owner Entain lifted 18.4p to 646.6p, boosted by better-than-expected first quarter growth in net gaming revenues of 11%. The figure, which is on a constant currency basis, includes the company’s 50% share of BetMGM.

FTSE 100 Live: Stocks crawl higher after AstraZeneca, BP and AB...

FTSE 100 up 20 points at 8,436 AstraZeneca results beat on earnings but revenues 'soft' BP profits and AB Foods guidance worse than expected HSBC, Entain and Howden Joinery results impress   11.02am: FTSE crawling higher The FTSE 100 has started to …

AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near

AstraZeneca posts another Truqap study fail, says China import tax could triple

AstraZeneca plots US expansion despite Trump tariff threat

AstraZeneca has doubled down on plans to grow its US business as it braces for the country’s potential tariffs on the pharmaceutical industry. The drug maker said it is “firmly committed to investing and growing in the US” despite President Donald Trump …